Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by johnny007on Jun 02, 2021 1:51pm
76 Views
Post# 33311749

difficult, but ..

difficult, but .... some progress, I agree with nailbiter regarding the PR company.

Assuming they will work on Aristotle and, OK, the covid tests.

The drive-in (or -by or -up, funny)  covid test PR today, hmm.
Don't know how that works, maybe good way to put the officers to work? /jk :-)

Saw the 0.55 break yesterday. Now traded on 2H 2020 support.

So here is the chance, have it bounce strongly back above .60 and make it go above
the upper BB on some expectations. That would be at least .75.

200dma is still around .85 waiting for Tripp ;-)

I am very critical and negative here, but even the worst stock can bounce every now and then.
Hey, Tripp, make it fly a little. Haha.

I know, not really funny. Bought a few shares .53 for the good old times.
If they follow up with proper Aristotle news, some PR - MAYBE SOME ACTUAL READY TO PURCHASE ADVERTISEMENT (you hear that Tripp) - it should walk back up a chunk.

They need to show Aristotle is real.
Good luck!

<< Previous
Bullboard Posts
Next >>